388 related articles for article (PubMed ID: 24731298)
1. Geographical variation in Plasmodium vivax relapse.
Battle KE; Karhunen MS; Bhatt S; Gething PW; Howes RE; Golding N; Van Boeckel TP; Messina JP; Shanks GD; Smith DL; Baird JK; Hay SI
Malar J; 2014 Apr; 13():144. PubMed ID: 24731298
[TBL] [Abstract][Full Text] [Related]
2. Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria.
Lover AA; Coker RJ
Emerg Infect Dis; 2013 Jul; 19(7):1058-65. PubMed ID: 23763820
[TBL] [Abstract][Full Text] [Related]
3. Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.
White MT; Shirreff G; Karl S; Ghani AC; Mueller I
Proc Biol Sci; 2016 Mar; 283(1827):20160048. PubMed ID: 27030414
[TBL] [Abstract][Full Text] [Related]
4. Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
Battle KE; Cameron E; Guerra CA; Golding N; Duda KA; Howes RE; Elyazar IR; Price RN; Baird JK; Reiner RC; Smith DL; Gething PW; Hay SI
Malar J; 2015 May; 14():191. PubMed ID: 25948111
[TBL] [Abstract][Full Text] [Related]
5. Determinants of relapse periodicity in Plasmodium vivax malaria.
White NJ
Malar J; 2011 Oct; 10():297. PubMed ID: 21989376
[TBL] [Abstract][Full Text] [Related]
6. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
Kim JR; Nandy A; Maji AK; Addy M; Dondorp AM; Day NP; Pukrittayakamee S; White NJ; Imwong M
PLoS One; 2012; 7(7):e39645. PubMed ID: 22808048
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Relapse.
White NJ; Imwong M
Adv Parasitol; 2012; 80():113-50. PubMed ID: 23199487
[TBL] [Abstract][Full Text] [Related]
9. Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia.
Golassa L; White MT
Malar J; 2017 Jul; 16(1):301. PubMed ID: 28750669
[TBL] [Abstract][Full Text] [Related]
10. The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.
Yang GJ; Shang LY; Zhou XN; Lee TE; Bi B; White M; Smith TA; Penny MA
BMC Med; 2022 Jan; 20(1):17. PubMed ID: 35057816
[TBL] [Abstract][Full Text] [Related]
11. Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa.
Zhong D; Lo E; Wang X; Yewhalaw D; Zhou G; Atieli HE; Githeko A; Hemming-Schroeder E; Lee MC; Afrane Y; Yan G
Malar J; 2018 May; 17(1):185. PubMed ID: 29720181
[TBL] [Abstract][Full Text] [Related]
12. Management of relapsing Plasmodium vivax malaria.
Chu CS; White NJ
Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
[TBL] [Abstract][Full Text] [Related]
13. Global Epidemiology of Plasmodium vivax.
Howes RE; Battle KE; Mendis KN; Smith DL; Cibulskis RE; Baird JK; Hay SI
Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):15-34. PubMed ID: 27402513
[TBL] [Abstract][Full Text] [Related]
14. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Hossain MS; Douglas NM; Humphreys GS; Sibley CH; Guerin PJ; Price RN
Lancet Infect Dis; 2019 Jan; 19(1):91-101. PubMed ID: 30587297
[TBL] [Abstract][Full Text] [Related]
15. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K
Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682
[TBL] [Abstract][Full Text] [Related]
17. The distribution of incubation and relapse times in experimental human infections with the malaria parasite Plasmodium vivax.
Lover AA; Zhao X; Gao Z; Coker RJ; Cook AR
BMC Infect Dis; 2014 Oct; 14():539. PubMed ID: 25280926
[TBL] [Abstract][Full Text] [Related]
18. A study on relapse/re-infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P. vivax in two endemic districts of Nepal.
Manandhar S; Bhusal CL; Ghimire U; Singh SP; Karmacharya DB; Dixit SM
Malar J; 2013 Sep; 12():324. PubMed ID: 24041296
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination.
Li Y; Hu Y; Zhao Y; Wang Q; Ngassa Mbenda HG; Kittichai V; Lawpoolsri S; Sattabongkot J; Menezes L; Liu X; Cui L; Cao Y
Malar J; 2020 Apr; 19(1):145. PubMed ID: 32268906
[TBL] [Abstract][Full Text] [Related]
20. The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006.
Chowell G; Munayco CV; Escalante AA; McKenzie FE
Malar J; 2009 Jun; 8():142. PubMed ID: 19558695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
